Hence, it plays a crucial role in essential metabolic pathways such as glycolysis and gluconeogenesis, mainly in the liver and skeletal muscles.[26] Low ALT was previously suggested as a biomarker for sarcopenia, clinically manifested as frailty, and subsequent increased risk of hospitalization and mortality. The gene discussed is GPT; the disease is sarcopenia.